Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02612571 · ClinicalTrials.gov registry record
Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players
A clinical trial, sponsored by Wills Eye.
- Completed
- Registry status
- 51
- Enrollment target
NCT02612571: Completed study, sponsored by Wills Eye.
NCT02612571 is a clinical trial that has completed, run by Wills Eye. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02612571 has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of the present study is to compare rates of glaucomatous optic neuropathy in professional wind versus non-wind instrument players in the Philadelphia Orchestra. A secondary objective is to evaluate intra-ocular pressure and choroidal thickness of wind instrument players under variable playing conditions.
Primary Outcome
Compare IOP in wind and non-wind instrument players
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-07 |
What the finished NCT02612571 record still lists
NCT02612571 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02612571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02612571 about?
NCT02612571 is a clinical study titled "Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players". The purpose of the present study is to compare rates of glaucomatous optic neuropathy in professional wind versus non-wind instrument players in the Philadelphia Orchestra. A secondary objective is to evaluate intra-ocular pressure and choroidal thickness of wind instrument players under variable pl...
What is the current status of trial NCT02612571?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2015-07. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT02612571?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia